ATE321876T1 - Enzymatisches verfahren zur herstellung von 4-0-b-d-galactopyranosyl-d-xylose, mit diesem verfahren gewonnene 4-0-b-d-galactopyranosyl-d-xylose, diese enthaltende zusammensetzungen und verwendung davon beim quantifiizieren intestinaler lactase - Google Patents

Enzymatisches verfahren zur herstellung von 4-0-b-d-galactopyranosyl-d-xylose, mit diesem verfahren gewonnene 4-0-b-d-galactopyranosyl-d-xylose, diese enthaltende zusammensetzungen und verwendung davon beim quantifiizieren intestinaler lactase

Info

Publication number: ATE321876T1
Authority: AT; Austria
Prior art keywords: xylose; galactopyranosyl; beta; bdg; substrate
Prior art date: 2001-06-18

Application number

AT02740774T

Other languages

English (en)

Inventor

Vicinay Francisco Javie Canada

Morales G Corrales

Lomas Manuel Martin

Reyes Juan Jose Aragon

Rectorado Edificio

Original Assignee

Consejo Superior Investigacion

Univ Madrid Autonoma

Vicinay Francisco Javie Canada

Corrales Morales Guillermo Ins

Fernandez Mayoralas Alvarez Al

Martin Lomas Manuel Inst De In

Aragon Reyes Juan Jose Univers

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-06-18

Filing date

2002-06-14

Publication date

2006-04-15

2002-06-14 Application filed by Consejo Superior Investigacion, Univ Madrid Autonoma, Vicinay Francisco Javie Canada, Corrales Morales Guillermo Ins, Fernandez Mayoralas Alvarez Al, Martin Lomas Manuel Inst De In, Aragon Reyes Juan Jose Univers filed Critical Consejo Superior Investigacion

2006-04-15 Application granted granted Critical

2006-04-15 Publication of ATE321876T1 publication Critical patent/ATE321876T1/de

Links

108010005774 beta-Galactosidase Proteins 0.000 title abstract 8
239000000203 mixture Substances 0.000 title abstract 5
238000000034 method Methods 0.000 title abstract 3
230000008569 process Effects 0.000 title abstract 3
102100026189 Beta-galactosidase Human genes 0.000 title 1
108010059881 Lactase Proteins 0.000 title 1
230000002255 enzymatic effect Effects 0.000 title 1
230000000968 intestinal effect Effects 0.000 title 1
229940116108 lactase Drugs 0.000 title 1
102000005936 beta-Galactosidase Human genes 0.000 abstract 7
239000000758 substrate Substances 0.000 abstract 5
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract 3
VEXXNWQUANSCBT-UHFFFAOYSA-N 4-O-beta-D-Galactopyranosyl-D-xylose Natural products OC1C(O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O VEXXNWQUANSCBT-UHFFFAOYSA-N 0.000 abstract 2
VCTBNHVCBSUQPG-MRRNQDDQSA-N 4-o-β-d-galactopyranosyl-d-xylose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)OC1 VCTBNHVCBSUQPG-MRRNQDDQSA-N 0.000 abstract 2
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract 2
TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 abstract 2
PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 abstract 2
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 2
SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 abstract 2
BYZQBCIYLALLPA-UHFFFAOYSA-N O4-beta-D-Galactopyranosyl-D-xylose Natural products O=CC(O)C(O)C(CO)OC1OC(CO)C(O)C(O)C1O BYZQBCIYLALLPA-UHFFFAOYSA-N 0.000 abstract 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 2
239000012062 aqueous buffer Substances 0.000 abstract 2
SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 abstract 2
238000002425 crystallisation Methods 0.000 abstract 2
230000008025 crystallization Effects 0.000 abstract 2
238000001914 filtration Methods 0.000 abstract 2
230000008014 freezing Effects 0.000 abstract 2
238000007710 freezing Methods 0.000 abstract 2
PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 abstract 2
238000002360 preparation method Methods 0.000 abstract 2
238000000956 solid--liquid extraction Methods 0.000 abstract 2
239000002904 solvent Substances 0.000 abstract 2
238000000605 extraction Methods 0.000 abstract 1
238000010438 heat treatment Methods 0.000 abstract 1
239000012429 reaction media Substances 0.000 abstract 1
238000000108 ultra-filtration Methods 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/12—Disaccharides

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Microbiology (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Saccharide Compounds (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Separation Using Semi-Permeable Membranes (AREA)
Extraction Or Liquid Replacement (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT02740774T 2001-06-18 2002-06-14 Enzymatisches verfahren zur herstellung von 4-0-b-d-galactopyranosyl-d-xylose, mit diesem verfahren gewonnene 4-0-b-d-galactopyranosyl-d-xylose, diese enthaltende zusammensetzungen und verwendung davon beim quantifiizieren intestinaler lactase ATE321876T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
ES200101419A ES2182703B1 (es)	2001-06-18	2001-06-18	Un procedimiento enzimatico para obtener 4-0-b-d-galactopiranosil-d-xilosa, 4-o-b-d-galactopiranosil-d-xilosa obtenida de acuerdo con el pr cedimiento, composiciones que la contienen y su uso en la evaluacion de la lactasa intestinal.

Publications (1)

Publication Number	Publication Date
ATE321876T1 true ATE321876T1 (de)	2006-04-15

Family

ID=8498115

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02740774T ATE321876T1 (de)	2001-06-18	2002-06-14	Enzymatisches verfahren zur herstellung von 4-0-b-d-galactopyranosyl-d-xylose, mit diesem verfahren gewonnene 4-0-b-d-galactopyranosyl-d-xylose, diese enthaltende zusammensetzungen und verwendung davon beim quantifiizieren intestinaler lactase

Country Status (12)

Country	Link
US (1)	US7537909B2 (de)
EP (1)	EP1408118B1 (de)
JP (1)	JP4115933B2 (de)
AT (1)	ATE321876T1 (de)
AU (1)	AU2002314215B2 (de)
CA (1)	CA2451065C (de)
DE (1)	DE60210278T2 (de)
ES (2)	ES2182703B1 (de)
MX (1)	MXPA03011869A (de)
PT (1)	PT1408118E (de)
RU (1)	RU2316593C2 (de)
WO (1)	WO2002103038A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1887017A1 (de) *	2006-08-09	2008-02-13	Friesland Brands B.V.	Praebiotische Kohenlhydraten
US9128100B2 (en)	2011-01-14	2015-09-08	Venter Pharma, S.L.	Non-invasive diagnostic method for the evaluation of intestinal lactase deficiency (hypolactasia)
CN107050915A (zh) *	2017-06-01	2017-08-18	湖北恒贸茶油有限公司	带结晶导出区的茶油结晶罐

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4228274A (en) *	1976-09-28	1980-10-14	Merck & Co., Inc.	1-Substituted glycopyranosides
US4130709A (en) *	1977-12-08	1978-12-19	Eli Lilly And Company	Pleuromutilin glycoside derivatives
SE8203925D0 (sv) *	1982-06-23	1982-06-23	Svenska Sockerfabriks Ab	New and novel glycosides, glycoconjugates and processes for their preparation
ES2023556A6 (es) *	1990-06-18	1992-01-16	Consejo Superior Investigacion	Procedimiento de obtencion de 4-o-beta-d-galactopiranosil-d-xilosa utilizable para la evaluacion diagnostica de la lactasa intestinal.
JPH09508783A (ja) *	1993-09-23	1997-09-09	ニユー・イングランド・バイオレイブス・インコーポレイテツド	新規なグリコシダーゼの単離及び組成物
ES2100131B1 (es) *	1995-11-08	1998-02-16	Consejo Superior Investigacion	Procedimiento enzimatico de obtencion de beta-d-galactopiranosil-d-xilosas utilizables para la evaluacion diagnostica de la lactasa intestinal.
ES2130073B1 (es) *	1997-05-28	2000-04-01	Consejo Superior Investigacion	Mejoras en el procedimiento de obtencion de beta-d-galactopiranosil-xilosas utilizables para la evaluacion diagnostica de la lactasa intestinal.

2001
- 2001-06-18 ES ES200101419A patent/ES2182703B1/es not_active Expired - Fee Related
2002
- 2002-06-14 ES ES02740774T patent/ES2260444T3/es not_active Expired - Lifetime
- 2002-06-14 CA CA2451065A patent/CA2451065C/en not_active Expired - Fee Related
- 2002-06-14 WO PCT/ES2002/000297 patent/WO2002103038A1/es not_active Ceased
- 2002-06-14 AU AU2002314215A patent/AU2002314215B2/en not_active Ceased
- 2002-06-14 AT AT02740774T patent/ATE321876T1/de not_active IP Right Cessation
- 2002-06-14 DE DE60210278T patent/DE60210278T2/de not_active Expired - Lifetime
- 2002-06-14 PT PT02740774T patent/PT1408118E/pt unknown
- 2002-06-14 RU RU2004101406/13A patent/RU2316593C2/ru active
- 2002-06-14 EP EP02740774A patent/EP1408118B1/de not_active Expired - Lifetime
- 2002-06-14 JP JP2003505359A patent/JP4115933B2/ja not_active Expired - Fee Related
- 2002-06-14 MX MXPA03011869A patent/MXPA03011869A/es active IP Right Grant
2003
- 2003-12-17 US US10/738,378 patent/US7537909B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
AU2002314215B2 (en)	2006-11-16
PT1408118E (pt)	2006-08-31
US7537909B2 (en)	2009-05-26
JP4115933B2 (ja)	2008-07-09
JP2004537298A (ja)	2004-12-16
US20040241811A1 (en)	2004-12-02
MXPA03011869A (es)	2005-03-07
EP1408118B1 (de)	2006-03-29
RU2004101406A (ru)	2005-05-10
WO2002103038A1 (es)	2002-12-27
ES2182703A1 (es)	2003-03-01
ES2182703B1 (es)	2004-06-01
DE60210278T2 (de)	2006-12-14
CA2451065A1 (en)	2002-12-27
DE60210278D1 (de)	2006-05-18
ES2260444T3 (es)	2006-11-01
EP1408118A1 (de)	2004-04-14
RU2316593C2 (ru)	2008-02-10
CA2451065C (en)	2012-09-11

Similar Documents

Publication	Publication Date	Title
DE60034566T2 (de)	2008-01-03	Peptidakzeptor ligationsverfahren
US20190135774A1 (en)	2019-05-09	Biomolecule processing from fixed biological samples
DE60030988D1 (de)	2006-11-09	Verfahren zur Herstellung Von L-Aminosäuren durch Erhöhung des zellulären NADPH
AU2535697A (en)	1997-10-10	Engineering affinity ligands for macromolecules
JPH01258669A (ja)	1989-10-16	イソフラボン化合物の製造法
AU2003281862A1 (en)	2004-02-23	Stabilisation of nucleic acids
ATE401413T1 (de)	2008-08-15	Verfahren zur herstellung von l-aminosäuren, unter verwendung von stämmen aus der familie der enterobacteriaceae, welche ein attenuiertes acea- gen enthalten
ATE321876T1 (de)	2006-04-15	Enzymatisches verfahren zur herstellung von 4-0-b-d-galactopyranosyl-d-xylose, mit diesem verfahren gewonnene 4-0-b-d-galactopyranosyl-d-xylose, diese enthaltende zusammensetzungen und verwendung davon beim quantifiizieren intestinaler lactase
JP2978518B2 (ja)	1999-11-15	ファージｄｎａの精製方法
Warzecha et al.	1999	Purification, partial amino acid sequence and structure of the product of raucaffricine-O-β-d-glucosidase from plant cell cultures of Rauwolfia serpentina
JP2005145824A (ja)	2005-06-09	ノビレチンの製造方法
ATE234934T1 (de)	2003-04-15	Verfahren zur herstellung von einem beta-laktam antibiotikum
DE69534954D1 (de)	2006-06-01	Methode zur Darstellung von Mikroorganismen welche resistent für organische Lösungsmittel sind, sowie organische Lösungsmittel resistente Mikroorganismen, durch diese Methode erhalten
WO2005093065A1 (en)	2005-10-06	Improved method of isolating nucleic acids
ATE388220T1 (de)	2008-03-15	Wodka und verfahren zur herstellung von wodka
DE2509482A1 (de)	1976-09-16	Verfahren zur herstellung des kallikrein-trypsin-inhibitors aus rinderlunge
WO2004050889A3 (de)	2004-08-12	Enzymatische herstellung von acylflavonoidderivaten
US20180305726A1 (en)	2018-10-25	METHOD FOR SELECTIVELY PRODUCING GINSENOSIDE F2, COMPOUND Mc OR COMPOUND O FROM SAPONINS OF GINSENG BY ENZYMATIC PROCESS
ATE321062T1 (de)	2006-04-15	Verfahren zur herstellung endotoxinfreier nukleinsäuren
WO2002033093A3 (en)	2003-02-27	Aggrecanase molecules
Gopalakrishnan et al.	2007	Easy-to-execute'One-pot'Synthesis of 1, 2, 4, 5-Tetrazines Catalyzed by Activated Fly Ash
IL43784A (en)	1977-04-29	Manufacture of hesperetin dihydrochalcone glucoside by means of an enzyme system
WO2000068395A3 (en)	2001-03-08	Sulfohydrolases, corresponding amino acid and nucleotide sequences, sulfohydrolase preparations, processes, and products thereof
RU2180918C1 (ru)	2002-03-27	Способ получения панкреатической рибонуклеазы
WO2003004607A3 (en)	2003-07-31	Aggrecanase molecules

Legal Events

Date	Code	Title	Description
2006-09-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties